Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00528.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Bochra Tourki und 19 weiteren Autor:innen. Beteiligte Einrichtung: Ubben Center for Pulmonary Fibrosis Research, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Morsani Coll…. Hauptthemen laut MEDLINE: COVID-19, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, USF | Morsani College of Medicine (MCOM), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).
Abstract (Originalsprache)
Changes in the 50-gene signature, reflective of increase in CD14 + HLA-DR low CD163 + monocytes and decrease in CD4 and CD8 T cells, are associated with increased mortality in COVID-19. A reversal of this pattern can be seen in post-COVID-19-ILD, whereas its persistence can be seen in IPF. Modulating the imbalance between HLA-DR low monocytes and T cell subsets should be investigated as a potential strategy to treat pulmonary fibrosis associated with severe COVID-19 and progressive IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ubben Center for Pulmonary Fibrosis Research, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United S…
- Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
- Joint Carnegie Mellon-University of Pittsburgh Computational Biology Ph.D. Program, Pittsburgh, Pennsylvania, United States.
- Division of infectious Disease, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
- Center for Advanced Lung Disease and Lung Transplant Program, Tampa General Hospital, Florida, United States.
- Department of Respiratory Medicine, University of Patras, Patras, Greece.
ORCID-Profile: Bochra Tourki, Carole Y Perrot, Muhammad R Qureshi, Jose D Herazo-Maya
Förderung
- NHLBI NIH HHS
- USF | Morsani College of Medicine (MCOM)
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Tourki, B., Jia, M., Karampitsakos, T., Vera, I. M., Arsenault, A., Fatima, Z., Perrot, C. Y., Allen, D., Farsaei, F., Rutenberg, D., Bandyopadhyay, D., Restrepo-Jaramillo, R., Qureshi, M. R., Patel, K., Tzouvelekis, A., Kapetanaki, M. G., Juan-Guardela, B. M., Kim, K., Benos, P. V., & Herazo-Maya, J. D. (2025). Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00528.2024
Vancouver
Tourki B, Jia M, Karampitsakos T, Vera IM, Arsenault A, Fatima Z, et al. Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00528.2024
BibTeX
@article{Tourki2025,
author = {Tourki, Bochra and Jia, Minxue and Karampitsakos, Theodoros and Vera, Iset M and Arsenault, Alyssa and Fatima, Zainab and Perrot, Carole Y and Allen, Dylan and Farsaei, Forouzandeh and Rutenberg, David and Bandyopadhyay, Debabrata and Restrepo-Jaramillo, Ricardo and Qureshi, Muhammad R and Patel, Kapilkumar and Tzouvelekis, Argyris and Kapetanaki, Maria G and Juan-Guardela, Brenda M and Kim, Kami and Benos, Panayiotis V and Herazo-Maya, Jose D},
title = {Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00528.2024}
}
EUVIMED